PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2025 Earnings Call Transcript
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2025 Earnings Call Transcript November 4, 2025PROCEPT BioRobotics Corporation beats earnings expectations.
Procept Biorobotics Corp (PRCT)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 9,126 | $325,707 | 0.01% | |
| 2. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.26 | 20,000 | $785,138.00 | 863,159 | 2025-08-13 | Filing | |
| $24.43 | 940 | $22,960.63 | 147,713 | 2022-03-11 | Filing | |
| $25.00 | 3,200 | $80,000.00 | 3,200 | 2021-09-17 | Filing | |
| $25.00 | 440,000 | $11,000,000.00 | 11,222,662 | 2021-09-17 | Filing | |
| $25.00 | 10,000 | $250,000.00 | 45,074 | 2021-09-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.33 | 5,049 | $314,692.56 | 14,363 | 2025-06-12 | Filing | |
| $61.28 | 19,951 | $1,222,563.36 | 19,412 | 2025-06-12 | Filing | |
| $64.27 | 5,717 | $367,447.03 | 39,363 | 2025-06-11 | Filing | |
| $63.47 | 11,495 | $729,602.59 | 45,080 | 2025-06-11 | Filing | |
| $62.59 | 7,788 | $487,475.84 | 56,575 | 2025-06-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,205,442 | $185,782,225 | 0% | |
| 2. | 4,220,489 | $150,629,253 | 0% | |
| 3. | 1,970,147 | $70,314,546 | 0.3% | |
| 4. | 1,568,845 | $55,992,060 | 1.38% | |
| 5. | 1,437,897 | $51,318,544 | 0.39% |
News See All
Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside.
11 Best Small Cap Stocks with the Highest Upside
She stated that small caps show possibility, as a lot of them are rate sensitive, a little bit more levered, and are helped by lower rates, which is why there has been a lot of momentum behind small caps...
PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts.
Top 10 Robotics Stocks to Buy According to Analysts
Markets and Markets research projects that the industrial robotics market will develop at a compound annual growth rate (CAGR) of 14% from $17 billion in 2024 to $35 billion by 2030.
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best medical device stocks to buy according to analysts. On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT...
12 Best Medical Device Stocks to Buy According to Analysts
On July 7, CNBC’s Chery Kang and Elaine Yu talked about China’s imposition of reciprocal tariffs on the import of medical devices from the European Union.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the PROCEPT BioRobotics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
What Makes PROCEPT BioRobotics Corporation (PRCT) an Investment Bet?
Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript April 24, 2025PROCEPT BioRobotics Corporation beats earnings expectations.